The Effect of Age on Immunologic Response to Recombinant Hepatitis B Vaccine: A Meta‐analysis
Open Access
- 1 December 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (11) , 1368-1375
- https://doi.org/10.1086/344271
Abstract
Hepatitis B vaccine is a key tool for the prevention of hepatitis B infection. Age-associated changes in immune function may contribute to decreasedKeywords
This publication has 41 references indexed in Scilit:
- Travel Vaccines and Elderly Persons: Review of Vaccines Available in the United StatesClinical Infectious Diseases, 2001
- ERADICATION OF VACCINE-PREVENTABLE DISEASESAnnual Review of Public Health, 1999
- Immunogenicity of Hepatitis B vaccines: Implications for persons at occupational risk of Hepatitis B virus infectionAmerican Journal of Preventive Medicine, 1998
- Immunogenicity of a recombinant hepatitis B vaccine in adultsArchives of internal medicine (1960), 1996
- Effect Of Age On The Immunogenicity Of Yeast Recombinant Hepatitis B Vaccines Containing Surface Antigen (S) Or Pres2+S AntigensThe Journal of Infectious Diseases, 1994
- Immune senescenceAnnals of Neurology, 1994
- Response to HBV vaccination in patients with severe liver diseaseDigestive Diseases and Sciences, 1992
- A prospective study of in vitro anti‐HBs producing B cells (spot‐ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controlsJournal of Medical Virology, 1991
- Immunogenicity of yeast-derived hepatitis B vaccine from two different producersEpidemiology and Infection, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986